European Biotech Acquisition Corp.
European Biotech Acquisition Corp. (EBAC) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · EBAC · as of Dec 31, 2022
Ownership Breakdown
51
Institutional Holders
▲ 2 vs Q3
$94.04M
Total Inst. Value
▲ $7.18M vs Q3
16.40M
Shares Outstanding
freeFloat 72.90%
9.31M
13F Shares Held
▲ 424,445 vs Q3
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
EBAC largest shareholders · institutional ownership
Q4 2022 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
GLAZER CAPITAL, LLC blank checks | 1.25M | 9.84% | 9.84% | $12.67B | Feb 14, 2023 | ▲ 259.3K |
PERISCOPE CAPITAL INC. blank checks | 776.8K | 6.09% | 6.09% | $7.85B | Feb 13, 2023 | ▼ 66.4K |
MILLENNIUM MANAGEMENT LLC blank checks | 593.0K | 4.65% | 4.65% | $5.99B | Feb 14, 2023 | ▼ 3.6K |
MACQUARIE GROUP LTD blank checks | 504.0K | 3.95% | 3.95% | $5.09B | Feb 21, 2023 | — held |
LINDEN ADVISORS LP blank checks | 498.0K | 3.90% | 3.90% | $5.03B | Feb 14, 2023 | — held |
MARSHALL WACE, LLP blank checks | 454.0K | 3.56% | 3.56% | $4.59B | Feb 14, 2023 | — held |
D. E. SHAW & CO., INC. blank checks | 408.6K | 3.20% | 3.20% | $4.13B | Feb 14, 2023 | ▲ 150.0K |
TYRUS CAPITAL S.A.M. blank checks | 400.0K | 3.14% | 3.14% | $4.04B | Feb 10, 2023 | NEW |
WOODLINE PARTNERS LP blank checks | 375.0K | 2.94% | 2.94% | $3.79B | Feb 14, 2023 | ▲ 100.0K |
SCULPTOR CAPITAL LP blank checks | 352.9K | 2.77% | 2.77% | $3.56B | Feb 14, 2023 | — held |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q4 2022 vs prior quarter
Q4 2022
5
Increased
+632.3K shares6
New Positions
first time holders6
Decreased
−185.7K shares0
Sold Out
fully exitedNet shares change (top 50)
+446.7K
+632.3K / −185.7K
Net new holders
+5
6 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
EBAC insider trading · insider activity
Source: SEC Form 4
Recent Insider Transactions
Showing 10 most recent · Common Stock only
No recent insider transactions reported.
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
European Biotech Acquisition Corp. (EBAC) is primarily owned by institutional investors, who hold approximately 56.8% of total shares outstanding. Company insiders own approximately 27.10%, while retail and public investors account for the remaining 16.12%.
The largest institutional shareholder of European Biotech Acquisition Corp. is GLAZER CAPITAL, LLC, holding approximately 1.25 million shares — equal to 9.84% of outstanding shares — as of December 31, 2022.
A total of 51 institutional investors currently hold EBAC stock, with a combined institutional value of approximately $94,044,039 as of the most recent 13F filing period.
Frequently asked questions
EBAC ownershipEuropean Biotech Acquisition Corp. (EBAC) is primarily owned by institutional investors, who hold approximately 56.8% of shares. The largest shareholder is GLAZER CAPITAL, LLC with a 9.84% stake. Company insiders hold 27.10%. Data sourced from SEC Form 13F as of December 31, 2022.